We focus on enterprise software (with a deep science component), computational biotech, and engineering and science ventures (eg quantum/photonics, robotics, advanced materials).

Our portfolio is concentrated in the UK and Europe and we provide a bridge to the USA and Asia.

Investments include large syndicated investments (2019-present) and smaller earlier angel checks.